Experts recommended the early use of anti-TNF therapy for patients with ulcerative colitis and Crohn disease, offering further input regarding the introduction, optimization, and maintenance of the treatment for patients with IBD.
/PRNewswire/ The "Prefilled Syringes Market by Therapeutic Area, Type of Syringe, Type of Material, Type of Molecule, and Key Geographical Regions: Industry.
KalVista Pharmaceuticals Presents New Data for Sebetralstat and its Oral Factor XIIa Inhibitor Program - read this article along with other careers information, tips and advice on BioSpace
Sebetralstat data examines efficacy by attack location and population PK comparisons - Preclinical data for oral Factor XIIa inhibitor shows durable suppression of kallikrein-kinin system - KalVista